image
Relay Therapeutics, Inc. RLAY
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.845
-6.23 %
$ 488 M
Market Cap
-1.3
P/E
Price Target Average
532.69%
Revenue Forecast Estimate
92.96%
EBIT Estimate
23.18%
Net Income Estimate
14.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Relay Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for RLAY of $18 , with forecasts ranging from a low of $16 to a high of $20 .
RLAY Lowest Price Target Wall Street Target
16 USD 462.39%
RLAY Average Price Target Wall Street Target
18 USD 532.69%
RLAY Highest Price Target Wall Street Target
20 USD 602.99%
Price
Max Price Target
Min Price Target
Average Price Target
20201818161614141212101088664422Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart RLAY

image
$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RLAY

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RLAY

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029